Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients

Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast... APPLIED METHODS Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients Joan L. Warren, PhD,* Angela Mariotto, PhD,* Danielle Melbert, BS,w Deborah Schrag, MD, MPH,z Paul Doria-Rose, PhD,* David Penson, MD, MPH,y and K. Robin Yabroff, PhD* Key Words: Medicare, SEER, health claims, recurrence, outcomes, Background: Researchers are increasingly interested in using ob- disease-free progression servational data to evaluate cancer outcomes following treatment, (Med Care 2013;00: 000–000) including cancer recurrence and disease-free survival. Because population-based cancer registries do not collect recurrence data, recurrence is often imputed from health claims, primarily by identifying later cancer treatments after initial treatment. The val- esearchers are increasingly interested in assessing out- idity of this approach has not been established. R comes such as recurrence and disease-free survival (DFS) following cancer treatment. Population-based cancer Research Design: We used the linked Surveillance, Epidemiology, registries collect information about all incident cancers re- and End Results-Medicare data to assess the sensitivity of Medicare ported within defined geographic areas and some registries claims for cancer recurrence in patients very likely to have had a also conduct follow-up of their patients to determine vital recurrence. We selected newly diagnosed stage II/III colorectal status. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Medical Care Wolters Kluwer Health

Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients

Medical Care , Volume Publish Ahead of Print – Dec 1, 2013

Loading next page...
 
/lp/wolters-kluwer-health/sensitivity-of-medicare-claims-to-identify-cancer-recurrence-in-aCgpmqBUKf

References (22)

Copyright
Copyright © 2013 by Lippincott Williams & Wilkins
ISSN
0025-7079
eISSN
1537-1948
DOI
10.1097/MLR.0000000000000058
pmid
24374419
Publisher site
See Article on Publisher Site

Abstract

APPLIED METHODS Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients Joan L. Warren, PhD,* Angela Mariotto, PhD,* Danielle Melbert, BS,w Deborah Schrag, MD, MPH,z Paul Doria-Rose, PhD,* David Penson, MD, MPH,y and K. Robin Yabroff, PhD* Key Words: Medicare, SEER, health claims, recurrence, outcomes, Background: Researchers are increasingly interested in using ob- disease-free progression servational data to evaluate cancer outcomes following treatment, (Med Care 2013;00: 000–000) including cancer recurrence and disease-free survival. Because population-based cancer registries do not collect recurrence data, recurrence is often imputed from health claims, primarily by identifying later cancer treatments after initial treatment. The val- esearchers are increasingly interested in assessing out- idity of this approach has not been established. R comes such as recurrence and disease-free survival (DFS) following cancer treatment. Population-based cancer Research Design: We used the linked Surveillance, Epidemiology, registries collect information about all incident cancers re- and End Results-Medicare data to assess the sensitivity of Medicare ported within defined geographic areas and some registries claims for cancer recurrence in patients very likely to have had a also conduct follow-up of their patients to determine vital recurrence. We selected newly diagnosed stage II/III colorectal status.

Journal

Medical CareWolters Kluwer Health

Published: Dec 1, 2013

There are no references for this article.